Therapeutic potential of promiscuous targets in Mycobacterium tuberculosis

Bei Shi Lee and Kevin Pethe

Current Opinion in Pharmacology, 2018, 42, 22
DOI: 10.1016/j.coph.2018.06.006

Exploring Scaffold Hopping for Novel 2-(Quinolin-4-yloxy)acetamides with Enhanced Antimycobacterial Activity

Ana Flávia Borsoi, Alessandro Silva Ramos, Nathalia Sperotto, Bruno Lopes Abbadi, Fernanda Souza Macchi Hopf, Adilio da Silva Dadda, Raoní Scheibler Rambo, Mauro Neves Muniz, Josiane Delgado Paz, Estevão Silveira Grams, Fernanda Fries da Silva, Kenia Pissinate, Luiza Galina, Laura Calle González, Lovaine Silva Duarte, Marcia Alberton Perelló, Alexia de Matos Czeczot, Cristiano Valim Bizarro, Luiz Augusto Basso and Pablo Machado

ACS Med. Chem. Lett., 2024, 15, 493
DOI: 10.1021/acsmedchemlett.3c00570

Features and Functional Importance of Key Residues of the Mycobacterium tuberculosis Cytochrome bd Oxidase

Ekaterina Sviriaeva, Malathy Sony Subramanian Manimekalai, Gerhard Grüber and Kevin Pethe

ACS Infect. Dis., 2020, 6, 1697
DOI: 10.1021/acsinfecdis.9b00449

Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical Disease

Clinton G. L. Veale

ChemMedChem, 2019, 14, 386
DOI: 10.1002/cmdc.201800755

Effect of common and experimental anti-tuberculosis treatments onMycobacterium tuberculosisgrowing as biofilms

James P. Dalton, Benedict Uy, Narisa Phummarin, Brent R. Copp, William A. Denny, Simon Swift and Siouxsie Wiles

PeerJ, 2016, 4, e2717
DOI: 10.7717/peerj.2717

Pyrazolo[1,5-a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis

Xiaoyun Lu, Zoe Williams, Kiel Hards, Jian Tang, Chen-Yi Cheung, Htin Lin Aung, Bangxing Wang, Zhiyong Liu, Xianglong Hu, Anne Lenaerts, Lisa Woolhiser, Courtney Hastings, Xiantao Zhang, Zhe Wang, Kyu Rhee, Ke Ding, Tianyu Zhang and Gregory M. Cook

ACS Infect. Dis., 2019, 5, 239
DOI: 10.1021/acsinfecdis.8b00225

Drug discovery in tuberculosis. New drug targets and antimycobacterial agents

André Campaniço, Rui Moreira and Francisca Lopes

European Journal of Medicinal Chemistry, 2018, 150, 525
DOI: 10.1016/j.ejmech.2018.03.020

An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates

Jody Phelan, Klaas Van den Heede, Serge Masyn, Rudi Verbeeck, Taane G. Clark, Dirk A. Lamprecht, Anil Koul and Richard J. Wall

Sci Rep, 2024, 14
DOI: 10.1038/s41598-024-75818-y

Triazolopyrimidines Target Aerobic Respiration in Mycobacterium tuberculosis

Catherine Shelton, Matthew McNeil, Renee Allen, Lindsay Flint, Dara Russell, Bryan Berube, Aaron Korkegian, Yulia Ovechkina and Tanya Parish

Antimicrob Agents Chemother, 2022, 66
DOI: 10.1128/aac.02041-21

Antitubercular Activity of Novel 2-(Quinoline-4-yloxy)acetamides with Improved Drug-Like Properties

Ana Flávia Borsoi, Laura Manzoli Alice, Nathalia Sperotto, Alessandro Silva Ramos, Bruno Lopes Abbadi, Fernanda Souza Macchi Hopf, Adilio da Silva Dadda, Raoní S. Rambo, Rodrigo Braccini Madeira Silva, Josiane Delgado Paz, Kenia Pissinate, Mauro Neves Muniz, Christiano Ev Neves, Luiza Galina, Laura Calle González, Marcia Alberton Perelló, Alexia de Matos Czeczot, Mariana Leyser, Sílvia Dias de Oliveira, Graziela de Araújo Lock, Bibiana Verlindo de Araújo, Teresa Dalla Costa, Cristiano Valim Bizarro, Luiz Augusto Basso and Pablo Machado

ACS Med. Chem. Lett., 2022, 13, 1337
DOI: 10.1021/acsmedchemlett.2c00254

Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing

Fernanda Teixeira Subtil, Anne Drumond Villela, Bruno Lopes Abbadi, Valnês S. Rodrigues-Junior, Cristiano Valim Bizarro, Luis Fernando Saraiva Macedo Timmers, Osmar Norberto de Souza, Kenia Pissinate, Pablo Machado, Alexandre López-Gavín, Griselda Tudó, Julian González-Martín, Luiz Augusto Basso and Diógenes Santiago Santos

International Journal of Antimicrobial Agents, 2018, 51, 378
DOI: 10.1016/j.ijantimicag.2017.08.023

No Evidence for Acquired Mutations Associated with Cytochrome bc 1 Inhibitor Resistance in 13,559 Clinical Mycobacterium tuberculosis Complex Isolates

Jan Rybniker, Thomas Andreas Kohl, Ivan Barilar and Stefan Niemann

Antimicrob Agents Chemother, 2019, 63
DOI: 10.1128/AAC.01317-18

Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics?

Sapna Bajeli, Navin Baid, Manjot Kaur, Ganesh P. Pawar, Vinod D. Chaudhari and Ashwani Kumar

Front. Cell. Infect. Microbiol., 2020, 10
DOI: 10.3389/fcimb.2020.589318

Unveiling the Antimycobacterial Potential of Novel 4-Alkoxyquinolines: Insights into Selectivity, Mechanism of Action, and In Vivo Exposure

Fernanda Fries da Silva, Josiane Delgado Paz, Raoní Scheibler Rambo, Guilherme Arraché Gonçalves, Mauro Neves Muniz, Alexia de Matos Czeczot, Marcia Alberton Perelló, Andresa Berger, Laura Calle González, Lovaine Silva Duarte, Anelise Baptista da Silva, Carlos Alexandre Sanchez Ferreira, Sílvia Dias de Oliveira, Sidnei Moura, Cristiano Valim Bizarro, Luiz Augusto Basso and Pablo Machado

J. Med. Chem., 2024, 67, 21781
DOI: 10.1021/acs.jmedchem.4c01302

Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB

Laura A. T. Cleghorn, Peter C. Ray, Joshua Odingo, Anuradha Kumar, Heather Wescott, Aaron Korkegian, Thierry Masquelin, Abraham Lopez Moure, Caroline Wilson, Susan Davis, Margaret Huggett, Penelope Turner, Alasdair Smith, Ola Epemolu, Fabio Zuccotto, Jennifer Riley, Paul Scullion, Yoko Shishikura, Liam Ferguson, Joaquin Rullas, Laura Guijarro, Kevin D. Read, Simon R. Green, Phil Hipskind, Tanya Parish and Paul G. Wyatt

J. Med. Chem., 2018, 61, 6592
DOI: 10.1021/acs.jmedchem.8b00172

Roles of Alanine Dehydrogenase and Induction of Its Gene in Mycobacterium smegmatis under Respiration-Inhibitory Conditions

Ji-A Jeong, Sae Woong Park, Dahae Yoon, Suhkmann Kim, Ho-Young Kang, Jeong-Il Oh and William W. Metcalf

J Bacteriol, 2018, 200
DOI: 10.1128/JB.00152-18

Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis

Vadim Makarov, Elena Salina, Robert C. Reynolds, Phyo Phyo Kyaw Zin and Sean Ekins

J. Med. Chem., 2020, 63, 8917
DOI: 10.1021/acs.jmedchem.9b02075

Targeting the cytochrome bc1 complex for drug development in M. tuberculosis: review

Mushtaq Ahmad Wani and Devendra Kumar Dhaked

Mol Divers, 2022, 26, 2949
DOI: 10.1007/s11030-021-10335-y

Targeting the cytochrome oxidases for drug development in mycobacteria

Bei Shi Lee, Ekaterina Sviriaeva and Kevin Pethe

Progress in Biophysics and Molecular Biology, 2020, 152, 45
DOI: 10.1016/j.pbiomolbio.2020.02.001

Anti-tubercular drug discovery: in silico implications and challenges

Rukmankesh Mehra, Inshad Ali Khan and Amit Nargotra

European Journal of Pharmaceutical Sciences, 2017, 104, 1
DOI: 10.1016/j.ejps.2017.03.028

Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis

Shipra Grover, Curtis A. Engelhart, Esther Pérez-Herrán, Wei Li, Katherine A. Abrahams, Kadamba Papavinasasundaram, James M. Bean, Christopher M. Sassetti, Alfonso Mendoza-Losana, Gurdyal S. Besra, Mary Jackson and Dirk Schnappinger

ACS Infect. Dis., 2021, 7, 141
DOI: 10.1021/acsinfecdis.0c00675

Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis

Milan Urban, Veronika Šlachtová and Lucie Brulíková

European Journal of Medicinal Chemistry, 2021, 212, 113139
DOI: 10.1016/j.ejmech.2020.113139

Computer-aided drug design approaches for the identification of potent inhibitors targeting elongation factor G of Mycobacterium tuberculosis

Mushtaq Ahmad Wani, Aritra Banerjee and Prabha Garg

Journal of Molecular Graphics and Modelling, 2025, 136, 108954
DOI: 10.1016/j.jmgm.2025.108954

Mycobacterial tuberculosis Enzyme Targets and their Inhibitors

Anil Kumar Saxena and Anamika Singh

CTMC, 2019, 19, 337
DOI: 10.2174/1568026619666190219105722

The Emerging Landscape of Tubercular Targets: A Medicinal Chemistry Approach

Baji Baba Shaik, Kimeshni Moodley, Safiyah Ghumran, Muhammad D. Bala, Parvesh Singh and Rajshekhar Karpoormath

Medicinal Research Reviews, 2025, 45, 1077
DOI: 10.1002/med.22100

A multi-targeting pre-clinical candidate against drug-resistant tuberculosis

Parvinder Kaur, Vijay Potluri, Vijay Kamal Ahuja, C.N. Naveenkumar, Ramya Vadageri Krishnamurthy, Shruthi Thimmalapura Gangadharaiah, Prasad Shivarudraiah, Sumesh Eswaran, Christy Rosaline Nirmal, Balasubramanian Mahizhaveni, Azger Dusthackeer, Rajesh Mondal, Sarah M. Batt, Emily J. Richardson, Nicholas J. Loman, Gurdyal Singh Besra, Radha Krishan Shandil and Shridhar Narayanan

Tuberculosis, 2021, 129, 102104
DOI: 10.1016/j.tube.2021.102104

QcrB in Mycobacterium tuberculosis: The new drug target of antitubercular agents

Aparna Bahuguna, Srishti Rawat and Diwan S. Rawat

Medicinal Research Reviews, 2021, 41, 2565
DOI: 10.1002/med.21779

Synthesis and antitubercular activity of novel 4-arylalkyl substituted thio-, oxy- and sulfoxy-quinoline analogues targeting the cytochrome bc1 complex

Robert Murnane, Mire Zloh, Sangeeta Tanna, Renee Allen, Felipe Santana-Gomez, Tanya Parish and Federico Brucoli

Bioorganic Chemistry, 2023, 138, 106659
DOI: 10.1016/j.bioorg.2023.106659

1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity

Fernanda Souza Macchi, Kenia Pissinate, Anne Drumond Villela, Bruno Lopes Abbadi, Valnês Rodrigues-Junior, Débora Dreher Nabinger, Stefani Altenhofen, Nathalia Sperotto, Adílio da Silva Dadda, Fernanda Teixeira Subtil, Talita Freitas de Freitas, Ana Paula Erhart Rauber, Ana Flávia Borsoi, Carla Denise Bonan, Cristiano Valim Bizarro, Luiz Augusto Basso, Diógenes Santiago Santos and Pablo Machado

European Journal of Medicinal Chemistry, 2018, 155, 153
DOI: 10.1016/j.ejmech.2018.06.005

Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis

Caroline S. Foo, Andréanne Lupien, Maryline Kienle, Anthony Vocat, Andrej Benjak, Raphael Sommer, Dirk A. Lamprecht, Adrie J. C. Steyn, Kevin Pethe, Jérémie Piton, Karl-Heinz Altmann, Stewart T. Cole and Carol A. Nacy

mBio, 2018, 9
DOI: 10.1128/mBio.01276-18

Oxidative Phosphorylation—an Update on a New, Essential Target Space for Drug Discovery in Mycobacterium tuberculosis

Caroline Shi-Yan Foo, Kevin Pethe and Andréanne Lupien

Applied Sciences, 2020, 10, 2339
DOI: 10.3390/app10072339

New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis

Bruno Couto Giacobbo, Kenia Pissinate, Valnês Rodrigues-Junior, Anne Drumond Villela, Estêvão Silveira Grams, Bruno Lopes Abbadi, Fernanda Teixeira Subtil, Nathalia Sperotto, Rogério Valim Trindade, Davi Fernando Back, Maria Martha Campos, Luiz Augusto Basso, Pablo Machado and Diógenes Santiago Santos

European Journal of Medicinal Chemistry, 2017, 126, 491
DOI: 10.1016/j.ejmech.2016.11.048

Structural and mechanistic study of a novel inhibitor analogue of M. tuberculosis cytochrome bc1:aa3

Amit K. Verma, Robbert Q. Kim, Dirk A. Lamprecht, Clara Aguilar-Pérez, Sarah Wong, Nicolas Veziris, Alexandra Aubry, José M. Bartolomé-Nebreda, Rodrigo J. Carbajo, Jennefer Wetzel and Meindert H. Lamers

npj Drug Discov., 2025, 2
DOI: 10.1038/s44386-025-00008-3

SAR Analysis of Small Molecules Interfering with Energy-Metabolism in Mycobacterium tuberculosis

Federico Appetecchia, Sara Consalvi, Cristina Scarpecci, Mariangela Biava and Giovanna Poce

Pharmaceuticals, 2020, 13, 227
DOI: 10.3390/ph13090227

New tuberculosis drug targets, their inhibitors, and potential therapeutic impact

Gauri S. Shetye, Scott G. Franzblau and Sanghyun Cho

Translational Research, 2020, 220, 68
DOI: 10.1016/j.trsl.2020.03.007

Mycobacterial Membrane Proteins QcrB and AtpE: Roles in Energetics, Antibiotic Targets, and Associated Mechanisms of Resistance

Luke Bown, Santosh K. Srivastava, Brandon M. Piercey, Clarissa K. McIsaac and Kapil Tahlan

J Membrane Biol, 2018, 251, 105
DOI: 10.1007/s00232-017-9997-3

Molecular Mechanisms of MmpL3 Function and Inhibition

John T. Williams and Robert B. Abramovitch

Microbial Drug Resistance, 2023, 29, 190
DOI: 10.1089/mdr.2021.0424

Identification of 4-Amino-Thieno[2,3- d ]Pyrimidines as QcrB Inhibitors in Mycobacterium tuberculosis

Gregory A. Harrison, Anne E. Mayer Bridwell, Megh Singh, Keshav Jayaraman, Leslie A. Weiss, Rachel L. Kinsella, Janessa S. Aneke, Kelly Flentie, Miranda E. Schene, Margaret Gaggioli, Samantha D. Solomon, Scott A. Wildman, Marvin J. Meyers, Christina L. Stallings and Paul Dunman

mSphere, 2019, 4
DOI: 10.1128/mSphere.00606-19